UONDDL
University of Notre Dame du Lac Portfolio holdings
AUM
$66.8M
This Quarter Return
+18.2%
1 Year Return
+43.52%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$316M
AUM Growth
+$316M
(-5.7%)
Cap. Flow
-$56.9M
Cap. Flow
% of AUM
-17.99%
Top 10 Holdings %
Top 10 Hldgs %
39.71%
Holding
65
New
9
Increased
9
Reduced
32
Closed
14
Top Buys
| 1 |
Corteva
CTVA
|
$9M |
| 2 |
Tyler Technologies
TYL
|
$8.52M |
| 3 |
Meta Platforms (Facebook)
META
|
$8.51M |
| 4 |
LPL Financial
LPLA
|
$8.23M |
| 5 |
Amazon
AMZN
|
$7.98M |
Top Sells
| 1 |
Morgan Stanley
MS
|
$9.08M |
| 2 |
Altice USA
ATUS
|
$8.88M |
| 3 |
MDCO
Medicines Co
MDCO
|
$8.53M |
| 4 |
Accenture
ACN
|
$8.45M |
| 5 |
PagSeguro Digital
PAGS
|
$8.34M |
Sector Composition
| 1 | Financials | 23.32% |
| 2 | Technology | 16.24% |
| 3 | Consumer Discretionary | 15.89% |
| 4 | Communication Services | 10.7% |
| 5 | Healthcare | 9.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Garrett Motion
GTX
$2.62B
| $7.83M | 2.48% | 784,052 +26,485 | +3% | +$265K |
|
|
GPOR
27
DELISTED
Gulfport Energy Corp.
GPOR
| $7.76M | 2.45% | 2,554,100 -242,021 | -9% | -$736K |
|
28
Crown Holdings
CCK
$11.6B
| $7.76M | 2.45% | 106,928 -21,002 | -16% | -$1.52M |
|
29
Alcon
ALC
$39.5B
| $7.61M | 2.41% | 134,595 -4,733 | -3% | -$268K |
|
|
GLIBA
30
DELISTED
GCI Liberty, Inc. Class A Common Stock (DE)
GLIBA
| $7.61M | 2.41% | 107,382 -101,921 | -49% | -$7.22M |
|
31
Vanguard FTSE Emerging Markets ETF
VWO
$96.4B
| $4.72M | 1.49% | 106,210 +1,314 | +1% | +$58.4K |
|
32
Kodiak Sciences
KOD
$478M
| $2.75M | 0.87% | +38,198 | New | +$2.75M |
|
|
DBVT
33
DBV Technologies
DBVT
$264M
| $1.38M | 0.44% | +129,326 | New | +$1.38M |
|
|
IGMS
34
DELISTED
IGM Biosciences
IGMS
| $1.36M | 0.43% | +35,528 | New | +$1.36M |
|
|
MYOK
35
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $1.33M | 0.42% | +18,263 | New | +$1.33M |
|
|
MRTX
36
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $1.19M | 0.38% | 9,263 -615 | -6% | -$79.3K |
|
37
Ascendis Pharma
ASND
$11.8B
| $1.19M | 0.38% | 8,563 +809 | +10% | +$113K |
|
38
argenx
ARGX
$43.6B
| $1.12M | 0.35% | 6,956 +349 | +5% | +$56K |
|
39
Exact Sciences
EXAS
$8.98B
| $1.12M | 0.35% | +12,061 | New | +$1.12M |
|
40
Heron Therapeutics
HRTX
$207M
| $1.08M | 0.34% | 45,860 -6,817 | -13% | -$160K |
|
41
BioMarin Pharmaceuticals
BMRN
$11.2B
| $1.07M | 0.34% | 12,645 +234 | +2% | +$19.8K |
|
42
Rhythm Pharmaceuticals
RYTM
$6.85B
| $1.02M | 0.32% | 44,390 -391 | -0.9% | -$8.98K |
|
|
TCDA
43
DELISTED
Tricida, Inc. Common Stock
TCDA
| $1.01M | 0.32% | 26,658 -616 | -2% | -$23.2K |
|
|
ALXN
44
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $976K | 0.31% | 9,025 +861 | +11% | +$93.1K |
|
45
Incyte
INCY
$16.5B
| $973K | 0.31% | 11,140 +96 | +0.9% | +$8.39K |
|
|
SGEN
46
DELISTED
Seagen Inc. Common Stock
SGEN
| $964K | 0.3% | 8,436 -3,169 | -27% | -$362K |
|
|
AMRN
47
Amarin Corp
AMRN
$311M
| $953K | 0.3% | 44,472 -17,179 | -28% | -$368K |
|
48
Neurocrine Biosciences
NBIX
$13.8B
| $935K | 0.3% | 8,698 -685 | -7% | -$73.6K |
|
49
Cerus
CERS
$251M
| $929K | 0.29% | 220,213 +49,340 | +29% | +$208K |
|
50
Acadia Pharmaceuticals
ACAD
$4.38B
| $899K | 0.28% | 21,018 -9,659 | -31% | -$413K |
|